Your browser doesn't support javascript.
loading
Recent progress in the use of mitochondrial membrane permeability transition pore in mitochondrial dysfunction-related disease therapies.
Cui, Yuting; Pan, Mingyue; Ma, Jing; Song, Xinhua; Cao, Weiling; Zhang, Peng.
Afiliación
  • Cui Y; School of Life Science, Shandong University of Technology, Zibo, Shandong Province, China.
  • Pan M; Department of Pharmacy, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong Province, China.
  • Ma J; The Eighth Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong Province, China.
  • Song X; School of Life Science, Shandong University of Technology, Zibo, Shandong Province, China.
  • Cao W; Department of Pharmacy, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong Province, China. 752557163@qq.com.
  • Zhang P; Department of Pharmacy, Shenzhen Luohu People's Hospital, Shenzhen, Guangdong Province, China. pzhang898018@163.com.
Mol Cell Biochem ; 476(1): 493-506, 2021 Jan.
Article en En | MEDLINE | ID: mdl-33000352
Mitochondria have various cellular functions, including ATP synthesis, calcium homeostasis, cell senescence, and death. Mitochondrial dysfunction has been identified in a variety of disorders correlated with human health. Among the many underlying mechanisms of mitochondrial dysfunction, the opening up of the mitochondrial permeability transition pore (mPTP) is one that has drawn increasing interest in recent years. It plays an important role in apoptosis and necrosis; however, the molecular structure and function of the mPTP have still not been fully elucidated. In recent years, the abnormal opening up of the mPTP has been implicated in the development and pathogenesis of diverse diseases including ischemia/reperfusion injury (IRI), neurodegenerative disorders, tumors, and chronic obstructive pulmonary disease (COPD). This review provides a systematic introduction to the possible molecular makeup of the mPTP and summarizes the mitochondrial dysfunction-correlated diseases and highlights possible underlying mechanisms. Since the mPTP is an important target in mitochondrial dysfunction, this review also summarizes potential treatments, which may be used to inhibit pore opening up via the molecules composing mPTP complexes, thus suppressing the progression of mitochondrial dysfunction-related diseases.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenosina Trifosfato / Enfermedades Mitocondriales / Poro de Transición de la Permeabilidad Mitocondrial Tipo de estudio: Systematic_reviews Límite: Animals / Humans Idioma: En Revista: Mol Cell Biochem Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Adenosina Trifosfato / Enfermedades Mitocondriales / Poro de Transición de la Permeabilidad Mitocondrial Tipo de estudio: Systematic_reviews Límite: Animals / Humans Idioma: En Revista: Mol Cell Biochem Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Países Bajos